Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Is treatment-resistant schizophrenia a neuroimmune condition? Meta-analytic evidence from magnetic resonance spectroscopy
    Published on 2024-07-18
    2 years ago
  • Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context matters
    Published on 2024-07-17
    2 years ago
  • Rewiring the brain: Inflammation’s impact on glutamate and neural networks in depression
    Published on 2024-07-17
    2 years ago
  • Virtual reality exposure therapy advances and potential for clinical and experimental use
    Published on 2024-07-17
    2 years ago
  • Pump the brakes: identifying neurobiological targets to enhance inhibitory control in drug addiction
    Published on 2024-07-17
    2 years ago
  • Brain-based graph-theoretical predictive modeling: a novel approach to prospectively map psychiatric symptoms
    Published on 2024-07-16
    2 years ago
  • Oxytocin treatment rescues irritability-like behavior in Cc2d1a conditional knockout mice
    Published on 2024-07-16
    2 years ago
« Previous 1 … 83 84 85 86 87 … 143 Next »
Journal of Psychopharmacology
  • To BDZ or not to BDZ? That is the question! Is there reliable scientific evidence for or against using benzodiazepines in the aftermath of potentially traumatic events for the prevention of PTSD? A systematic review and meta-analysis
    Published on 2022-04-19
    4 years ago
  • Do antipsychotic drugs shrink the brain? Probably not
    Published on 2022-04-09
    4 years ago
  • The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms
    Published on 2022-04-09
    4 years ago
  • Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms
    Published on 2022-04-07
    4 years ago
  • Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
    Published on 2022-04-07
    4 years ago
  • Clozapine and the aryl hydrocarbon receptor
    Published on 2022-04-01
    4 years ago
  • The effect of metformin on cognitive function: A systematic review and meta-analysis
    Published on 2022-03-17
    4 years ago
« Previous 1 … 83 84 85 86 87 … 150 Next »
European Neuropsychopharmacology
  • Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders
    Published on 2022-07-08
    4 years ago
  • Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan
    Published on 2022-07-07
    4 years ago
  • The potential of TAAR1 agonists in bipolar disorder
    Published on 2022-07-06
    4 years ago
  • The antipsychotic paradox: Lessons regarding determinants of premature mortality
    Published on 2022-07-03
    4 years ago
  • Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors: Glutathione in COVID-19
    Published on 2022-06-29
    4 years ago
  • Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery
    Published on 2022-06-26
    4 years ago
  • Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder
    Published on 2022-06-26
    4 years ago
« Previous 1 … 83 84 85 86 87 … 168 Next »

   Pharma Pub